Chirurgie cardiothoracique et vasculaire (pédiatrie)
Gestion et optimisation de l’hémostase
Antifibrinolytiques
Avoiding transfusions in children undergoing cardiac surgery: a meta-analysis of randomized trials of aprotinin. (manokatra rohy)
Loharanon-kevitra: Anesth Analg 2006;102(3):731-7.
Rakitra: PubMed 16492820
DOI: 10.1213/01.ane.0000194954.64293.61
https://www.ncbi.nlm.nih.gov/pubmed/16492820 (manokatra rohy)
A systematic review of the use of antifibrinolytic agents in pediatric surgery and implications for craniofacial use. (manokatra rohy)
Loharanon-kevitra: Pediatr Surg Int 2012;28(11):1059-69.
Rakitra: PubMed 22940882
DOI: 10.1007/s00383-012-3167-6
https://www.ncbi.nlm.nih.gov/pubmed/22940882 (manokatra rohy)
Aprotinin, transfusions, and kidney injury in neonates and infants undergoing cardiac surgery. (manokatra rohy)
Loharanon-kevitra: Br J Anaesth 2012;108(5):830-7.
Rakitra: PubMed 22362670
DOI: 10.1093/bja/aes002
https://www.ncbi.nlm.nih.gov/pubmed/22362670 (manokatra rohy)
Comparison of epsilon aminocaproic acid and tranexamic acid in pediatric cardiac surgery. (manokatra rohy)
Loharanon-kevitra: J Cardiothorac Vasc Anesth 2004;18(2):141-3.
Rakitra: PubMed 15073700
https://www.ncbi.nlm.nih.gov/pubmed/15073700 (manokatra rohy)
Efficacy of aprotinin, epsilon aminocaproic acid, or combination in cyanotic heart disease. (manokatra rohy)
Loharanon-kevitra: Ann Thorac Surg 2000;70(4):1308-12.
Rakitra: PubMed 11081890
https://www.ncbi.nlm.nih.gov/pubmed/11081890 (manokatra rohy)
The Bayer 022 compassionate-use pediatric study. (manokatra rohy)
Loharanon-kevitra: Ann Thorac Surg 1998;65(6 Suppl):S31-3.
Rakitra: PubMed 9647135
https://www.ncbi.nlm.nih.gov/pubmed/9647135 (manokatra rohy)
Differential effects of aprotinin and tranexamic acid on outcomes and cytokine profiles in neonates undergoing cardiac surgery. (manokatra rohy)
Loharanon-kevitra: J Thorac Cardiovasc Surg 2012;143(5):1069-76.
Rakitra: PubMed 22075061
DOI: 10.1016/j.jtcvs.2011.08.051
https://www.ncbi.nlm.nih.gov/pubmed/22075061 (manokatra rohy)
Minimizing perioperative blood loss and transfusions in children. [Réduire les pertes sanguines et les besoins transfusionnels en chirurgie pédiatrique.] [English, French abstract] (manokatra rohy)
Loharanon-kevitra: Can J Anaesth 2006;53(6 Suppl):S59-67.
Rakitra: PubMed 16766791
https://www.ncbi.nlm.nih.gov/pubmed/16766791 (manokatra rohy)
Intraoperative tranexamic acid in pediatric bloodless cardiac surgery. (manokatra rohy)
Loharanon-kevitra: Asian Cardiovasc Thorac Ann 2014;22(9):1039-45.
Rakitra: PubMed 24637029
DOI: 10.1177/0218492314527991
https://www.ncbi.nlm.nih.gov/pubmed/24637029 (manokatra rohy)
The safety and efficacy of antifibrinolytic therapy in neonatal cardiac surgery. (manokatra rohy)
Loharanon-kevitra: PLoS One 2015;10(5):e0126514.
Rakitra: PubMed 25954976
DOI: 10.1371/journal.pone.0126514
https://www.ncbi.nlm.nih.gov/pubmed/25954976 (manokatra rohy)
Epsilon aminocaproic acid reduces blood transfusion and improves the coagulation test after pediatric open-heart surgery: a meta-analysis of 5 clinical trials. (manokatra rohy)
Loharanon-kevitra: Int J Clin Exp Pathol 2015;8(7):7978-87.
Rakitra: PubMed 26339364
https://www.ncbi.nlm.nih.gov/pubmed/26339364 (manokatra rohy)
Tranexamic acid versus ɛ-aminocaproic acid: efficacy and safety in paediatric cardiac surgery. (manokatra rohy)
Loharanon-kevitra: Eur J Cardiothorac Surg 2011;39(6):892-7.
Rakitra: PubMed 21115357
DOI: 10.1016/j.ejcts.2010.09.041
https://www.ncbi.nlm.nih.gov/pubmed/21115357 (manokatra rohy)
Replacement of aprotinin by ε-aminocaproic acid in infants undergoing cardiac surgery: consequences for blood loss and outcome. (manokatra rohy)
Loharanon-kevitra: Br J Anaesth 2013;110(4):615-21.
Rakitra: PubMed 23213034
DOI: 10.1093/bja/aes430
https://www.ncbi.nlm.nih.gov/pubmed/23213034 (manokatra rohy)
Hematologic and economic impact of aprotinin in reoperative pediatric cardiac operations. (manokatra rohy)
Loharanon-kevitra: Ann Thorac Surg 1998;66(2):535-40; discussion 541.
Rakitra: PubMed 9725399
https://www.ncbi.nlm.nih.gov/pubmed/9725399 (manokatra rohy)
Efficacy of tranexamic acid as compared to aprotinin in open heart surgery in children. (manokatra rohy)
Loharanon-kevitra: Ann Card Anaesth 2015;18(1):23-6.
Rakitra: PubMed 25566706
DOI: 10.4103/0971-9784.148316
https://www.ncbi.nlm.nih.gov/pubmed/25566706 (manokatra rohy)
Comparative analysis of antifibrinolytic medications in pediatric heart surgery. (manokatra rohy)
Loharanon-kevitra: J Thorac Cardiovasc Surg 2012;143(3):550-7.
Rakitra: PubMed 22264414
DOI: 10.1016/j.jtcvs.2011.06.048
https://www.ncbi.nlm.nih.gov/pubmed/22264414 (manokatra rohy)
The efficacy of tranexamic acid versus placebo in decreasing blood loss in pediatric patients undergoing repeat cardiac surgery. (manokatra rohy)
Loharanon-kevitra: Anesth Analg 1997;84(5):990-6.
Rakitra: PubMed 9141920
https://www.ncbi.nlm.nih.gov/pubmed/9141920 (manokatra rohy)
Effective tranexamic acid concentration for 95% inhibition of tissue-type plasminogen activator induced hyperfibrinolysis in children with congenital heart disease: A prospective, controlled, in-vitro study. (manokatra rohy)
Loharanon-kevitra: Eur J Anaesthesiol 2015;32(12):844-50.
Rakitra: PubMed 26258658
DOI: 10.1097/EJA.0000000000000316
https://www.ncbi.nlm.nih.gov/pubmed/26258658 (manokatra rohy)
Comparison of different doses of ε-aminocaproic acid in children for tetralogy of Fallot surgery: clinical efficacy and safety. (manokatra rohy)
Loharanon-kevitra: J Cardiothorac Vasc Anesth 2013;27(1):23-9.
Rakitra: PubMed 22995453
DOI: 10.1053/j.jvca.2012.07.001
https://www.ncbi.nlm.nih.gov/pubmed/22995453 (manokatra rohy)
Comparison of three dose regimens of aprotinin in infants undergoing the arterial switch operation. (manokatra rohy)
Loharanon-kevitra: Ann Card Anaesth 2010;13(2):110-5.
Rakitra: PubMed 20442540
DOI: 10.4103/0971-9784.62935
https://www.ncbi.nlm.nih.gov/pubmed/20442540 (manokatra rohy)
Pharmacokinetics of tranexamic acid in neonates, infants, and children undergoing cardiac surgery with cardiopulmonary bypass. (manokatra rohy)
Loharanon-kevitra: Anesthesiology 2015;122(4):746-58.
Rakitra: PubMed 25585004
DOI: 10.1097/ALN.0000000000000570
https://www.ncbi.nlm.nih.gov/pubmed/25585004 (manokatra rohy)
Efficacy and safety of aprotinin in neonatal congenital heart operations. (manokatra rohy)
Loharanon-kevitra: Ann Thorac Surg 2011;92(3):958-63.
Rakitra: PubMed 21871283
DOI: 10.1016/j.athoracsur.2011.04.094
https://www.ncbi.nlm.nih.gov/pubmed/21871283 (manokatra rohy)
The effect of preoperative tranexamic acid on blood loss after cardiac operations in children. (manokatra rohy)
Loharanon-kevitra: J Thorac Cardiovasc Surg 1996;111(5):982-7.
Rakitra: PubMed 8622323
https://www.ncbi.nlm.nih.gov/pubmed/8622323 (manokatra rohy)
Facteur VII activé recombinant (rFVIIa)
Recombinant factor seven therapy for postoperative bleeding in neonatal and pediatric cardiac surgery. (manokatra rohy)
Loharanon-kevitra: Ann Thorac Surg 2007;84(1):161-8.
Rakitra: PubMed 17588404
DOI: 10.1016/j.athoracsur.2007.02.051
https://www.ncbi.nlm.nih.gov/pubmed/17588404 (manokatra rohy)
Pediatric off-label use of recombinant factor VIIa. (manokatra rohy)
Loharanon-kevitra: Pediatrics 2009;123(3):1066-72.
Rakitra: PubMed 19255041
DOI: 10.1542/peds.2008-1685
https://www.ncbi.nlm.nih.gov/pubmed/19255041 (manokatra rohy)
Factor VII for excessive bleeding following congenital heart disease surgery. (manokatra rohy)
Loharanon-kevitra: Asian Cardiovasc Thorac Ann 2012;20(2):120-5.
Rakitra: PubMed 22499956
DOI: 10.1177/0218492311433614
https://www.ncbi.nlm.nih.gov/pubmed/22499956 (manokatra rohy)
Use of recombinant factor VIIa for uncontrolled bleeding in neonates after cardiopulmonary bypass. (manokatra rohy)
Loharanon-kevitra: Paediatr Anaesth 2009;19(4):364-70.
Rakitra: PubMed 19143947
DOI: 10.1111/j.1460-9592.2008.02905.x
https://www.ncbi.nlm.nih.gov/pubmed/19143947 (manokatra rohy)
Review of the off-label use of recombinant activated factor VII in pediatric cardiac surgery patients. (manokatra rohy)
Loharanon-kevitra: Anesth Analg 2012;115(2):364-78.
Rakitra: PubMed 22652310
DOI: 10.1213/ANE.0b013e31825aff10
https://www.ncbi.nlm.nih.gov/pubmed/22652310 (manokatra rohy)
Is recombinant activated factor VII effective in the treatment of excessive bleeding after paediatric cardiac surgery? (manokatra rohy)
Loharanon-kevitra: Interact Cardiovasc Thorac Surg 2012;15(4):690-4.
Rakitra: PubMed 22811512
DOI: 10.1093/icvts/ivs309
https://www.ncbi.nlm.nih.gov/pubmed/22811512 (manokatra rohy)
Cardiac surgery without blood products in a Jehovah's Witness child with factor VII deficiency. (manokatra rohy)
Loharanon-kevitra: J Cardiothorac Vasc Anesth 2012;26(4):651-3.
Rakitra: PubMed 21924639
DOI: 10.1053/j.jvca.2011.07.012
https://www.ncbi.nlm.nih.gov/pubmed/21924639 (manokatra rohy)
Use of recombinant activated factor VII for controlling refractory postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass. (manokatra rohy)
Loharanon-kevitra: J Cardiothorac Vasc Anesth 2011;25(6):987-94.
Rakitra: PubMed 21835642
DOI: 10.1053/j.jvca.2011.05.012
https://www.ncbi.nlm.nih.gov/pubmed/21835642 (manokatra rohy)
Increased recombinant activated factor VII use and need for surgical reexploration following a switch from aprotinin to epsilon-aminocaproic acid in infant cardiac surgery. (manokatra rohy)
Loharanon-kevitra: J Clin Anesth 2014;26(3):204-11.
Rakitra: PubMed 24809789
DOI: 10.1016/j.jclinane.2013.10.015
https://www.ncbi.nlm.nih.gov/pubmed/24809789 (manokatra rohy)
Recombinant activated factor VII for hemorrhage after pediatric cardiac surgery. (manokatra rohy)
Loharanon-kevitra: Asian Cardiovasc Thorac Ann 2012;20(1):19-23.
Rakitra: PubMed 22371937
DOI: 10.1177/0218492311432584
https://www.ncbi.nlm.nih.gov/pubmed/22371937 (manokatra rohy)
Recombinant factor VIIa to treat bleeding after cardiac surgery in an infant. (manokatra rohy)
Loharanon-kevitra: Pediatr Crit Care Med 2003;4(1):49-51.
Rakitra: PubMed 12656542
DOI: 10.1097/01.PCC.0000031472.55687.4E
https://www.ncbi.nlm.nih.gov/pubmed/12656542 (manokatra rohy)
Recombinant factor VIIa to control excessive bleeding following surgery for congenital heart disease in pediatric patients. (manokatra rohy)
Loharanon-kevitra: J Intensive Care Med 2004;19(5):270-3.
Rakitra: PubMed 15358945
DOI: 10.1177/0885066604267783
https://www.ncbi.nlm.nih.gov/pubmed/15358945 (manokatra rohy)
Recombinant activated factor VII in cardiac surgery: a systematic review. (manokatra rohy)
Loharanon-kevitra: Ann Thorac Surg 2007;83(2):707-14.
Rakitra: PubMed 17258029
DOI: 10.1016/j.athoracsur.2006.10.033
https://www.ncbi.nlm.nih.gov/pubmed/17258029 (manokatra rohy)
Defining the role of recombinant activated factor VII in pediatric cardiac surgery: where should we go from here? (manokatra rohy)
Loharanon-kevitra: Pediatr Crit Care Med 2009;10(5):572-82.
Rakitra: PubMed 19451849
DOI: 10.1097/PCC.0b013e3181a642d5
https://www.ncbi.nlm.nih.gov/pubmed/19451849 (manokatra rohy)
Decreasing the need for transfusion: infant cardiac surgery using hemodilution and recombinant factor VIIa. (manokatra rohy)
Loharanon-kevitra: Pediatr Cardiol 2013;34(1):119-24.
Rakitra: PubMed 22760694
DOI: 10.1007/s00246-012-0398-1
https://www.ncbi.nlm.nih.gov/pubmed/22760694 (manokatra rohy)
Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder. (manokatra rohy)
Loharanon-kevitra: Pediatr Hematol Oncol 2008;25(4):301-11.
Rakitra: PubMed 18484474
DOI: 10.1080/08880010802016904
https://www.ncbi.nlm.nih.gov/pubmed/18484474 (manokatra rohy)
Concentrés de facteurs de coagulation
Perioperative monitoring of thromboelastograph on blood protection and recovery for severely cyanotic patients undergoing complex cardiac surgery. (manokatra rohy)
Loharanon-kevitra: Artif Organs 2010;34(11):955-60.
Rakitra: PubMed 21092037
DOI: 10.1111/j.1525-1594.2010.01148.x
https://www.ncbi.nlm.nih.gov/pubmed/21092037 (manokatra rohy)
Plasma fibrinogen concentration is correlated with postoperative blood loss in children undergoing cardiac surgery. A retrospective review. (manokatra rohy)
Loharanon-kevitra: Eur J Anaesthesiol 2014;31(6):317-26.
Rakitra: PubMed 24503704
DOI: 10.1097/EJA.0000000000000043
https://www.ncbi.nlm.nih.gov/pubmed/24503704 (manokatra rohy)
Efficacy and safety of fibrinogen concentrate in surgical patients: a meta-analysis of randomized controlled trials. (manokatra rohy)
Loharanon-kevitra: J Cardiothorac Vasc Anesth 2016;30(5):1196-204.
Rakitra: PubMed 27493092
DOI: 10.1053/j.jvca.2016.04.015
https://www.ncbi.nlm.nih.gov/pubmed/27493092 (manokatra rohy)
Hemostatic effects of fibrinogen concentrate compared with cryoprecipitate in children after cardiac surgery: a randomized pilot trial. (manokatra rohy)
Loharanon-kevitra: J Thorac Cardiovasc Surg 2014;148(4):1647-55.
Rakitra: PubMed 24951020
DOI: 10.1016/j.jtcvs.2014.04.029
https://www.ncbi.nlm.nih.gov/pubmed/24951020 (manokatra rohy)
Four-factor prothrombin complex concentrates in paediatric patients—a retrospective case series. (manokatra rohy)
Loharanon-kevitra: Vox Sang 2016;110(3):253-7.
Rakitra: PubMed 26509839
DOI: 10.1111/vox.12353
https://www.ncbi.nlm.nih.gov/pubmed/26509839 (manokatra rohy)
Desmopressine
Minimizing perioperative blood loss and transfusions in children. [Réduire les pertes sanguines et les besoins transfusionnels en chirurgie pédiatrique.] [English, French abstract] (manokatra rohy)
Loharanon-kevitra: Can J Anaesth 2006;53(6 Suppl):S59-67.
Rakitra: PubMed 16766791
https://www.ncbi.nlm.nih.gov/pubmed/16766791 (manokatra rohy)
Anesthetic management in a pediatric patient with Noonan syndrome, mastocytosis, and von Willebrand disease: a case report. (manokatra rohy)
Loharanon-kevitra: AANA J 2007;75(4):261-4.
Rakitra: PubMed 17711156
https://www.ncbi.nlm.nih.gov/pubmed/17711156 (manokatra rohy)
Agents hémostatiques topiques
A comprehensive review of topical hemostatic agents: efficacy and recommendations for use. (manokatra rohy)
Loharanon-kevitra: Ann Surg 2010;251(2):217-28.
Rakitra: PubMed 20010084
DOI: 10.1097/SLA.0b013e3181c3bcca
https://www.ncbi.nlm.nih.gov/pubmed/20010084 (manokatra rohy)
Resternotomy in pediatric cardiac surgery: CoSeal initial experience. (manokatra rohy)
Loharanon-kevitra: Interact Cardiovasc Thorac Surg 2007;6(1):21-3.
Rakitra: PubMed 17669759
DOI: 10.1510/icvts.2006.141531
https://www.ncbi.nlm.nih.gov/pubmed/17669759 (manokatra rohy)
Tests viscoélastiques pour distinguer une hémorragie chirurgicale d'une coagulopathie
Utility of Sonoclot analysis and tranexamic acid in tetralogy of Fallot patients undergoing intracardiac repair. (manokatra rohy)
Loharanon-kevitra: Ann Card Anaesth 2012;15(1):26-31.
Rakitra: PubMed 22234018
DOI: 10.4103/0971-9784.91477
https://www.ncbi.nlm.nih.gov/pubmed/22234018 (manokatra rohy)
Perioperative monitoring of thromboelastograph on blood protection and recovery for severely cyanotic patients undergoing complex cardiac surgery. (manokatra rohy)
Loharanon-kevitra: Artif Organs 2010;34(11):955-60.
Rakitra: PubMed 21092037
DOI: 10.1111/j.1525-1594.2010.01148.x
https://www.ncbi.nlm.nih.gov/pubmed/21092037 (manokatra rohy)
Thromboelastometry-guided intraoperative haemostatic management reduces bleeding and red cell transfusion after paediatric cardiac surgery. (manokatra rohy)
Loharanon-kevitra: Br J Anaesth 2015;114(1):91-102.
Rakitra: PubMed 25303988
DOI: 10.1093/bja/aeu339
https://www.ncbi.nlm.nih.gov/pubmed/25303988 (manokatra rohy)